ABRAXAS2 and thyroid cancer: The role of ABRO1 may be clinically relevant, because ABRO1 protein levels are reduced in several cancerous tissues, including liver, kidney, breast, and thyroid cancers, and a higher ABRO1 expression level correlates with better survival in patients [47].